---
layout: post
title: "港股和誉涨超50%"
date: 2022-06-06 10:05:15 +0800
categories: jiemianxinwen
tags: 界面新闻新闻
---
<p>6月6日上午，港股和誉涨超50%，和誉公告称，泛FGFR抑制剂ABSK091与替雷利珠单抗联合用药在尿路上皮癌中II期研究获得国家药监局临试批准。</p><p class="em_media">（文章来源：界面新闻）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202206062402155762>

[返回界面新闻新闻](//finews.withounder.com/category/jiemianxinwen.html)｜[返回首页](//finews.withounder.com/)